Search Results - "Syrigos, K N"

Refine Results
  1. 1

    Hormones of adipose tissue and their biologic role in lung cancer by Ntikoudi, E, Kiagia, M, Boura, P, Syrigos, K.N

    Published in Cancer treatment reviews (01-02-2014)
    “…Abstract Introduction Adipose tissue secretes numerous bioactive peptides, collectively termed “adipocytokines” or “adipokines”. Adipokines act in a paracrine,…”
    Get full text
    Journal Article
  2. 2

    Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review by Vathiotis, I. A., Syrigos, N. K., Dimakakos, E. P.

    “…Low-molecular-weight heparins are approved for primary and secondary venous thromboembolism prevention. Tinzaparin is the low-molecular-weight heparin with the…”
    Get full text
    Book Review Journal Article
  3. 3

    Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC by Pallis, A.G, Syrigos, K.N

    Published in Lung cancer (Amsterdam, Netherlands) (01-05-2013)
    “…Abstract Improvements in our understanding of the molecular biology of cancer have shifted management of lung cancer toward molecular-guided, individualized…”
    Get full text
    Journal Article
  4. 4

    Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer by KIRBY, A. M, A'HERN, R. P, D'AMBROSIO, C, TANAY, M, SYRIGOS, K. N, ROGERS, S. J, BOX, C, ECCLES, S. A, NUTTING, C. M, HARRINGTON, K. L

    Published in British journal of cancer (13-03-2006)
    “…To assess the level of activity and toxicity of gefitinib (ZD1839, Iressatrade mark) in a population of patients with locally recurrent and/or metastatic head…”
    Get full text
    Journal Article
  5. 5

    Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer by Syrigos, K.N., Vansteenkiste, J., Parikh, P., von Pawel, J., Manegold, C., Martins, R.G., Simms, L., Sugarman, K.P., Visseren-Grul, C., Scagliotti, G.V.

    Published in Annals of oncology (01-03-2010)
    “…Baseline patient and disease characteristics are investigated in non-small-cell lung cancer (NSCLC) in an effort to predict response to treatment and optimize…”
    Get full text
    Journal Article
  6. 6

    Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery by Alexiou, D, Karayiannakis, A.J, Syrigos, K.N, Zbar, A, Kremmyda, A, Bramis, I, Tsigris, C

    Published in European journal of cancer (1990) (01-12-2001)
    “…The serum concentrations of the cell adhesion molecules E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)…”
    Get full text
    Journal Article
  7. 7

    Desmoplasia in Pancreatic Cancer. Can We Fight It? by Merika, E. E., Syrigos, Kostas N., Saif, Muhammad Wasif

    Published in Gastroenterology research and practice (01-01-2012)
    “…The hallmark of pancreatic tumours, the desmoplastic reaction, provides a unique microenvironment that affects pancreatic tumour behaviour, its ability to grow…”
    Get full text
    Journal Article
  8. 8

    Targeted therapy for oesophageal cancer: an overview by Syrigos, K. N., Zalonis, A., Kotteas, E., Saif, Muhammad Wasif

    Published in Cancer and metastasis reviews (01-06-2008)
    “…Oesophageal cancer (OC), is an aggressive cancer constituting a major cause of cancer-related deaths worldwide. Recent advances in surgical techniques,…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival by PITKIN, L, LUANGDILOK, S, SYRIGOS, K. N, NUTTING, C. M, BARBACHANO, Y, ECCLES, S, HARRINGTON, K. J, CORBISHLEY, C, WILSON, P. O. G, DALTON, P, BRAY, D, MADY, S, WILLIAMSON, P, ODUTOYE, T, RHYS EVANS, P

    Published in British journal of cancer (28-08-2007)
    “…The aim of this study was to evaluate the expression of CC chemokine receptor 7 (CCR7) in squamous cell cancer of the tonsil with respect to patterns of…”
    Get full text
    Journal Article
  11. 11

    E-cadherin/catenin complex in benign and malignant melanocytic lesions by Silye, R., Karayiannakis, A. J., Syrigos, K. N., Poole, S., Van Noorden, S., Batchelor, W., Regele, H., Sega, W., Boesmueller, H., Krausz, T., Pignatelli, M.

    Published in The Journal of pathology (01-12-1998)
    “…E‐cadherin is a calcium‐dependent cell–cell adhesion molecule expressed by melanocytes and responsible for their adhesion to keratinocytes in vitro. In this…”
    Get full text
    Journal Article
  12. 12

    Management of non-Hodgkin's lymphoma of the thyroid : the Royal Marsden Hospital experience by HARRINGTON, K. J, MICHALAKI, V. J, VINI, L, NUTTING, C. M, SYRIGOS, K. N, A'HERN, R, HARMER, C. L

    Published in British journal of radiology (01-05-2005)
    “…A retrospective review was conducted of patients treated for thyroid non-Hodgkin's lymphoma (TNHL) at the Royal Marsden Hospital between 1936 and 1996 to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer by Syrigos, K N, Harrington, K, Waxman, J, Krausz, T, Pignatelli, M

    Published in The Journal of urology (01-11-1998)
    “…We studied the expression of alpha-, beta-, gamma- catenin and E-cadherin in transitional cell carcinoma (TCC) and normal bladder epithelium and correlated…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Epidemiology and diagnosis of pulmonary embolism in lung cancer patients: is there a role for age adjusted D-dimers cutoff? by Anagnostopoulos, I., Lagou, S., Spanorriga, M. K., Tavernaraki, K., Poulakou, G., Syrigos, K. N., Thanos, L.

    Published in Journal of thrombosis and thrombolysis (01-05-2020)
    “…Our knowledge about the incidence of pulmonary embolism (PE) and the performance of age adjusted D-dimers (Dd) cutoff amongst patients with lung cancer (LC)…”
    Get full text
    Journal Article
  17. 17

    Circulating Soluble E-Cadherin Levels are of Prognostic Significance in Patients with Multiple Myeloma by SYRIGOS, K. N, HARRINGTON, K. J, KARAYIANNAKIS, A. J, BAIBAS, N, KATIRTZOGLOU, N, ROUSSOU, P

    Published in Anticancer research (01-05-2004)
    “…Background: The epithelial transmembrane molecule E-cadherin (E-Cad) is the prime mediator of epithelial cell-cell adhesion, through homotypic interactions. It…”
    Get full text
    Journal Article
  18. 18

    Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients by Karayiannakis, A J, Syrigos, K N, Polychronidis, A, Pitiakoudis, M, Bounovas, A, Simopoulos, K

    Published in Anticancer research (01-03-2001)
    “…Tumour necrosis factor-alpha (TNF-alpha) is a multifunctional cytokine associated with cancer-related cachexia. In this study we evaluated serum levels of…”
    Get more information
    Journal Article
  19. 19

    Venous Thromboembolism in Patients Diagnosed With Lung Cancer by Salla, E., Dimakakos, Evangelos P., Tsagkouli, S., Giozos, I., Charpidou, A., Kainis, E., Syrigos, K. N.

    Published in Angiology (01-09-2016)
    “…Purpose: Considering the high prevalence of lung cancer, our purpose was to summarize the existing literature to identify the several factors that contribute…”
    Get full text
    Journal Article
  20. 20

    Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations by Syrigos, K N, Epenetos, A A

    Published in Anticancer research (01-01-1999)
    “…Over the last decade several attempts have been made to generate an active drug from an inactive precursor, by the action of an enzyme present predominantly at…”
    Get more information
    Journal Article